3 transcripts
Earnings call transcript
2024 Q2
1 Aug 24
due to lower research and development and general and administrative expenses, which was partially offset by a decrease in revenue and an impairment
Earnings call transcript
2024 Q1
2 May 24
in overall operating expenses resulted from a decrease in both research and development expense as well as a decrease in general and administrative expense
Earnings call transcript
2023 Q4
6 Mar 24
as an $8.2 million in research support and other payments from our other partners.
Research and development expense was $143.6 million in 2023 compared
- Prev
- 1
- Next